MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
MicroTech Medical (Hangzhou) Co., Ltd.
Sector
Healthcare
Industry
Medical - Devices
Employees
702
First IPO Date
October 19, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Pan Zheng | Executive Chairman & Chief Executive Officer | 1M | 1971 |
| Fangling Xu | Vice President & Head of Administration Department | 107,515 | 1985 |
| Fei Yu | Chief Technology Officer & Executive Director | 739,218 | 1982 |
| Xiu Liu | Executive Director & Financial Controller | 854,255 | 1980 |
| Yonghui Shi | Senior Vice President, Chief Strategy & Development Officer, Joint Company Secretary and Executive Director | 1.74M | 1981 |
| Pik Man Chu | Joint Company Secretary | 0 | 1997 |
| Yi Lan | Vice President of Marketing | 0 | 1972 |
Description
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
